Amgen today announced new interim results from the global Phase 3 DeLLphi-304 trial showing IMDELLTRA® (tarlatamab-dlle) reduced the risk of death by 40% and significantly extended median overall ...

Argomax enables low-temperature, low-pressure sintering for advanced power module bonding. The material supports more efficient, lightweight EV powertrain systems, directly enhancing range and ...